Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry

Pierpaolo Di Micco; Manuel Monreal

doi:10.2147/JBM.S234053

Platelet Count and Bleeding in Patients Receiving Anticoagulant Therapy for Venous Thromboembolism: Lesson from the RIETE Registry

J Blood Med. 2019 Dec 31:10:453-456. doi: 10.2147/JBM.S234053. eCollection 2019.

Authors

Pierpaolo Di Micco¹, Manuel Monreal²

Affiliations

¹ Department of Internal Medicine and Emergency Room, Ospedale Buon Consiglio Fatebenefratelli, Naples, Italy.
² Department of Internal Medicine, Hospital Universitari Germans Trias i Pujol, Universidad Autónoma de Barcelona, Badalona, Barcelona, Spain.

Abstract

Major bleeding is one of the most dangerous complications for patients undergoing anticoagulant treatment for VTE. Several clinical scores have been planned to identify patients at higher risk of bleeding, and most of them take into consideration the number of platelets in particular if lower than normal. Here we report the clinical experience made with the RIETE registry concerning anticoagulant treatment in the presence of different values of platelets and their related risk of bleeding.

Keywords: bleeding; bleeding risk; thrombocytopenia; venous thromboembolism.

Publication types

Review